Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine

France

St.Antoine

Contact Information for physicians and patients

Hepatology Department
CHU Paris Est – Hôpital Saint-Antoine
184 rue du Faubourg Saint-Antoine
75012 PARIS
France
+33 (0)1 49 28 28 36
zohra.jali@aphp.fr 

ERN Representatives

  • sara-lemoinne.jpg

    Sara Lemoinne

    Coordinator of the MIVB-H reference centre
    HCP REPRESENTATIVE

  • christophe-corpechot.jpg

    Christophe Corpechot

    HCP SUB-REPRESENTATIVE

Particular rare liver disease expertise of the centre

  • Primary biliary cholangitis (PBC)
  • Primary sclerosing cholangitis (PSC)
  • Autoimmune Hepatitis (AIH)
  • Low phospholipid-associated cholelithiasis (LPAC)
  • IgG4-related sclerosing cholangitis
  • Intrahepatic cholestasis of pregnancy
  • Benign recurrent intrahepatic cholestasis
  • Caroli Disease
  • Congenital hepatic fibrosis
  • Multiple Biliary Hamartomas
  • Choledochal cyst
  • Dubin-Johnson Syndrome
  • Rotor Syndrome

ERN Team and Contact

Medical department physicians:

  • Medical department physicians:
  • Prof Sara Lemoinne, Coordinator of the MIVB-H reference centre, E-mail: sara.lemoinne@aphp.fr (Secretariat : 33 (0) 1 49 28 28 36)
  • Prof Olivier Chazouillères, Coordinator of the Filfoie Health Network, E-mail: olivier.chazouilleres@aphp.fr (Secretariat: 33 (0) 1 49 28 23 78)
  • Dr Christophe Corpechot, E-mail: christophe.corpechot@aphp.fr (Secretariat: 33 (0) 1 49 28 28 36)
  • Dr Pierre-Antoine Soret,  E-mail: pierre.soret@aphp.fr (Secretariat: 33 (0) 1 49 28 28 36)

Other medical department staff:

Fundamental Research Team: 

INSERM Research Unit: "Maladies biliaires et métaboliques du foie, CRSA, Sorbonne Université, Paris, France"

Centre information

The Reference Centre for Inflammatory Biliary Diseases and Autoimmune Hepatitis “Centre de Référence des Maladies Inflammatoires des Voies Biliaires et des Hépatites auto-immunes” (CRMIVB-H) is the coordination centre (CRMR) of the French national network for rare inflammatory and autoimmune liver diseases (MIVB-H). It is located within the Hepatology Department at the Saint Antoine Hospital, which is part of the Public Assistance Hospitals of Paris (AP-HP).

Accredited by the French Ministry of Health since 2005, the CRMIVB-H is a highly specialised centre with recognised expertise in the management, research, and training related to rare inflammatory and autoimmune liver diseases. The CRMIVB-H hosts a multidisciplinary team with major expertise in rare hepatobiliary diseases, hepatology, liver transplantation and hepatobiliary surgery, hepatology intensive care, as well as related departments of anatomopathology, imaging, molecular genetics, immunology, interventional endoscopy, specialised biochemistry, epidemiology, and statistical methodology.

As a coordination centre, the CRMIVB-H manages the activities and cooperative actions of the MIVB-H network. The MIVB-H network includes 28 French healthcare centres with expertise in the management of rare inflammatory and autoimmune liver diseases in both adults and children. These care centres were officially accredited by the French Ministry of Health in 2008, as part of the national rare diseases plans (Plans Nationaux Maladies Rares, PNMRs). These national plans aim to structure a high level of care for rare diseases and to improve the visibility of the system established for both patients and healthcare professionals.

In addition to the CRMIVB-H coordination centre, the MIVB-H network includes 4 constitutive reference centres (Hôpital Bicêtre, Villejuif, Lyon, and Nantes), which were re-accredited by the French Ministry of Health in 2023 and contribute to the CRMR missions.

The CRMIVB-H, together with the CRMVF and the CRAVB-CG, are the French reference centres dedicated to rare liver diseases. They belong to the Filfoie rare diseases network, of which they form an integral part. Among the 23 French rare diseases networks (Filières de Santé des Maladies Rares), created by the French Ministry of Health and Solidarity in 2015 as part of the second rare diseases plan (PNMR2), Filfoie is the network dedicated to adult and paediatric rare liver diseases.

The purpose of the Filfoie network is to manage and coordinate actions by bringing together reference and competence centres, diagnostic laboratories, research units, universities, educational, social and medico-social structures, and patient organisations.